Dental pulp stem cells as a promising model to study imprinting diseases

Abstract

Parental imprinting is an epigenetic process leading to monoallelic expression of certain genes depending on their parental origin. Imprinting diseases are characterized by growth and metabolic issues starting from birth to adulthood. They are mainly due to methylation defects in imprinting control region that drive the abnormal expression of imprinted genes. We currently lack relevant animal or cellular models to unravel the pathophysiology of growth failure in these diseases. We aimed to characterize the methylation of imprinting regions in dental pulp stem cells and during their differentiation in osteogenic cells (involved in growth regulation) to assess the interest of this cells in modeling imprinting diseases. We collected dental pulp stem cells from five controls and four patients (three with Silver-Russell syndrome and one with Beckwith-Wiedemann syndrome). Methylation analysis of imprinting control regions involved in these syndromes showed a normal profile in controls and the imprinting defect in patients. These results were maintained in dental pulp stem cells cultured under osteogenic conditions. Furthermore, we confirmed the same pattern in six other loci involved in imprinting diseases in humans. We also confirmed monoallelic expression of H19 (an imprinted gene) in controls and its biallelic expression in one patient. Extensive imprinting control regions methylation analysis shows the strong potential of dental pulp stem cells in modeling imprinting diseases, in which imprinting regions are preserved in culture and during osteogenic differentiation. This will allow to perform in vitro functional and therapeutic tests in cells derived from dental pulp stem cells and generate other cell-types.

References

[1] Eggermann, T. et al. Imprinting disorders: a group of congenital disorders with overlapping patterns of molecular changes affecting imprinted loci. Clin. Epigenetics 7, 123 (2015).

[2] DeChiara TM, Robertson EJ, Efstratiadis A. Parental imprinting of the mouse insulin-like growth factor II gene. Cell, 1991, 64: 849-859.

[3] Silver HK, Kiyasu W, George J, Deamer WC. Syndrome of congenital hemihypertrophy, shortness of stature, and elevated urinary gonadotropins. Pediatrics, 1953, 12: 368-376.

[4] Russell A. A syndrome of intra-uterine dwarfism recognizable at birth with cranio-facial dysostosis, disproportionately short arms, and other anomalies (5 examples). Proc. R. Soc. Med., 1954, 47: 1040-1044.

[5] Wakeling EL, . Diagnosis and management of Silver-Russell syndrome: first international consensus statement. Nat. Rev. Endocrinol., 2017, 13: 105-124.

[6] Gicquel C, . Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver-Russell syndrome. Nat. Genet., 2005, 37: 1003-1007.

[7] Eggermann, K., Bliek, J., Brioude, F. & Mackay, D. J. EMQN best practice guidelines for genetic testing of chromosome 11p15 Imprinting Disorders - Silver-Russell and Beckwith-Wiedemann syndrome. Eur. J. Hum. Genet. 24, 1377–1387 (2016).

[8] Brioude F, . Expert consensus document: clinical and molecular diagnosis, screening and management of Beckwith-Wiedemann syndrome: an international consensus statement. Nat. Rev. Endocrinol., 2018, 14: 229-249.

[9] Mussa A, . Cancer risk in Beckwith-Wiedemann Syndrome: a systematic review and meta-analysis outlining a novel (Epi)genotype specific histotype targeted screening protocol. J. Pediatr., 2016, 176: 142-149. e1

[10] Patten, M. M., Cowley, M., Oakey, R. J. & Feil, R. Regulatory links between imprinted genes: evolutionary predictions and consequences. Proc. Biol. Sci. 283, 20152760 (2016).

[11] Abi Habib, W. et al. Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders. Sci. Adv. 5, eaau9425 (2019).

[12] Gabory A, . H19 acts as a trans regulator of the imprinted gene network controlling growth in mice. Dev. Camb. Engl., 2009, 136: 3413-3421.

[13] Monnier P, . H19 lncRNA controls gene expression of the Imprinted Gene Network by recruiting MBD1. Proc. Natl Acad. Sci. USA, 2013, 110: 20693-20698.

[14] Stelzer Y, Sagi I, Yanuka O, Eiges R, Benvenisty N. The noncoding RNA IPW regulates the imprinted DLK1-DIO3 locus in an induced pluripotent stem cell model of Prader-Willi syndrome. Nat. Genet., 2014, 46: 551-557.

[15] Whipple AJ, . Imprinted maternally expressed microRNAs antagonize paternally driven gene programs in neurons. Mol. Cell, 2020, 78: 85-95. e8

[16] Bar, S. & Benvenisty, N. Epigenetic aberrations in human pluripotent stem cells. EMBO J. 38 (2019).

[17] Stadtfeld M, . Ascorbic acid prevents loss of Dlk1-Dio3 imprinting and facilitates generation of all-iPS cell mice from terminally differentiated B cells. Nat. Genet., 2012, 44: 398-405. S1-2

[18] Velychko S, . Excluding Oct4 from Yamanaka cocktail unleashes the developmental potential of iPSCs. Cell Stem Cell, 2019, 25: 737-753. e4

[19] Yagi M, . De novo DNA methylation at imprinted loci during reprogramming into naive and primed pluripotency. Stem Cell Rep., 2019, 12: 1113-1128.

[20] Lee Chong, T., Ahearn, E. L. & Cimmino, L. Reprogramming the epigenome with vitamin C. Front. Cell Dev. Biol. 7,128 (2019).

[21] Grybek V, . Methylation and transcripts expression at the imprinted GNAS locus in human embryonic and induced pluripotent stem cells and their derivatives. Stem Cell Rep., 2014, 3: 432-443.

[22] Gronthos S, Mankani M, Brahim J, Robey PG, Shi S. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc. Natl Acad. Sci. USA, 2000, 97: 13625-13630.

[23] Frost JM, . The effects of culture on genomic imprinting profiles in human embryonic and fetal mesenchymal stem cells. Epigenetics, 2011, 6: 52-62.

[24] Elli F, Boldrin V, Pirelli A, Spada A, Mantovani G. The complex GNAS imprinted locus and mesenchymal stem cells differentiation. Horm. Metab. Res., 2016, 49: 250-258.

[25] Pignolo RJ, . Heterozygous inactivation of Gnas in adipose-derived mesenchymal progenitor cells enhances osteoblast differentiation and promotes heterotopic ossification. J. Bone Miner. Res., 2011, 26: 2647-2655.

[26] Dunaway K, . Dental pulp stem cells model early life and imprinted DNA methylation patterns. Stem Cells Dayt. Ohio, 2017, 35: 981-988.

[27] Nishino K, Umezawa A. DNA methylation dynamics in human induced pluripotent stem cells. Hum. Cell, 2016, 29: 97-100.

[28] Geoffron S, . Chromosome 14q32.2 imprinted region disruption as an alternative molecular diagnosis of Silver-Russell syndrome. J. Clin. Endocrinol. Metab., 2018, 103: 2436-2446.

[29] Poole RL, . Targeted methylation testing of a patient cohort broadens the epigenetic and clinical description of imprinting disorders. Am. J. Med. Genet. A., 2013, 161A: 2174-2182.

[30] Kagami, M. et al. Temple syndrome: comprehensive molecular and clinical findings in 32 Japanese patients. Genet. Med. (2017) https://doi.org/10.1038/gim.2017.53.

[31] Horii T, . Successful generation of epigenetic disease model mice by targeted demethylation of the epigenome. Genome Biol., 2020, 21

[32] Fanganiello RD, . Increased in vitro osteopotential in SHED associated with higher IGF2 expression when compared with hASCs. Stem Cell Rev. Rep., 2015, 11: 635-644.

[33] Miura M, . SHED: Stem cells from human exfoliated deciduous teeth. Proc. Natl Acad. Sci. USA, 2003, 100: 5807-5812.

[34] Salmon B, . MEPE-derived ASARM peptide inhibits odontogenic differentiation of dental pulp stem cells and impairs mineralization in tooth models of X-linked hypophosphatemia. PLoS ONE, 2013, 8: e56749.

[35] Zuk PA, . Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell, 2002, 13: 4279-4295.

[36] Monterubbianesi R, . A comparative in vitro study of the osteogenic and adipogenic potential of human dental pulp stem cells, gingival fibroblasts and foreskin fibroblasts. Sci. Rep., 2019, 9

[37] Collignon A-M, . Sclerostin deficiency promotes reparative dentinogenesis. J. Dent. Res., 2017, 96: 815-821.

[38] Novais, A. et al. Priming dental pulp stem cells from human exfoliated deciduous teeth with fibroblast growth factor‐2 enhances mineralization within tissue‐engineered constructs implanted in craniofacial bone defects. Stem Cells Transl. Med. (2019) https://doi.org/10.1002/sctm.18-0182.

[39] Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res., 1988, 16: 1215.

[40] Yang P-J, . Effects of long noncoding RNA H19 polymorphisms on urothelial cell carcinoma development. Int. J. Environ. Res. Public. Health, 2019, 16: E1322.

Funding

Agence Nationale de la Recherche (French National Research Agency)(18-CE12-022, 18-CE12-022)